Company Filing History:
Years Active: 2012-2013
Title: The Innovative Mind of Mario Maldonado
Introduction
Mario Maldonado, based in Basel, Switzerland, exemplifies the role of a modern inventor dedicated to advancing medical science. With a focus on developing innovative treatments for cancer and obesity, his contributions to the field have earned him two patents, reflecting his commitment to addressing significant health challenges faced by society.
Latest Patents
Maldonado's latest innovations include two pivotal patents:
1. **Method for treating cancers having high glucose requirements employing an SGLT2 inhibitor and compositions thereof** - This patent details methods for treating metastatic cancers that exhibit high glucose needs and elevated levels of SGLT2 expression, which are often found in aggressive forms like metastatic lung cancer. The methods involve the use of SGLT2 inhibitors either alone or alongside cytotoxic agents, providing a potential new avenue for cancer treatment.
2. **Methods for treating obesity employing an SGLT2 inhibitor** - This patent outlines methods to manage obesity or induce weight loss through the administration of SGLT2 inhibitors, either independently or in combination with other anti-obesity medications. The patent also includes a formulation incorporating these components, aiming to assist individuals in maintaining a healthier weight.
Career Highlights
Mario Maldonado serves as an innovator at Bristol-Myers Squibb Company, where he leverages his expertise and creativity to further advancements in pharmacological treatments. His work is characterized by a strong emphasis on research and development in the field of biopharmaceuticals, particularly focusing on metabolic and oncological therapies.
Collaborations
Throughout his career, Maldonado has collaborated with distinguished colleagues, including William N. Washburn and Jean Whaley. These partnerships underscore the importance of teamwork in the scientific community, as they share insights and knowledge to foster innovative solutions that can transform patient care.
Conclusion
Mario Maldonado represents a vital force in the intersection of innovation and medicine. Through his groundbreaking patents and collaborative efforts at Bristol-Myers Squibb, he continues to contribute to critical advancements in the treatment of cancer and obesity, ultimately aiming to enhance the quality of life for countless individuals. His work exemplifies the spirit of innovation that is essential to progress in healthcare.